Navigation Links
EAU Completes Approval Process for Electrolyzed Water as Sanitation Process for Industrial Clean-in-Place Application
Date:9/15/2009

ATLANTA, Sept. 15 /PRNewswire-FirstCall/ -- EAU Technologies Inc. ("EAU" or "Company") (OTC Bulletin Board: EAUI), a leading provider of electrolyzed water for high-volume, business-to-business applications, announced today that the company has completed a trial with a leading international beverage bottling company enabling the approval of the use of electrolyzed water technology as a sanitation process for CIP (Clean-in-Place) applications. EAU's electrolyzed water (Empowered Water(TM)) is an effective, environmentally friendly solution for Clean-in-Place (CIP) applications for industrial use. CIP applications are used in the food industry to clean stationary equipment during a product changeover and system start-up.

EAU began the extensive trial last fall with the goal of demonstrating that an ambient temperature solution, EAU's Empowered Water(TM), is an effective sanitation process for CIP applications. As part of the test, Empowered Water(TM) was used to clean and sanitize filling equipment and in product changeover applications. The rigorous and methodical testing included verification of cleaning efficacy, effectiveness for eliminating taste carryover, environmental safety, as well as financial enhancement with regards to improved CIP times and potential water and energy savings.

Empowered Water(TM) by EAU is created by combining salt and potable water with an electrical charge. EAU generators create two streams of Empowered Water. Primacide B is an effective cleaning fluid used as a replacement for caustic surfactants and cleaners. Primacide C is stabilized, non-toxic, acidic water effective at killing pathogens during the sanitation process. The active ingredient in Primacide C is Hypochlorous Acid, one of the same chemicals a human body creates to fight off sickness.

Results showed Empowered Water(TM) was able to maintain, and in some cases impr
'/>"/>

SOURCE EAU Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4

Related biology technology :

1. Karolinska Development Portfolio Company Completes Successful Phase II Clinical Trial
2. ACD Completes the Second Closing of Series A Financing and Initiates Services for Biomarker Validation and Companion Diagnostic Development
3. Pacific Biometrics Completes $4 Million Debt Financing
4. Alexza Stockholders Approve Share Issuance to Symphony Capital and Alexza Completes Acquisition of Symphony Allegro
5. Peptimmune Completes Phase Ib Study of PI-2301 in Multiple Sclerosis Patients, and Presentation at ECTRIMS 2009
6. Cephalon Completes Acquisition of Arana Therapeutics
7. Cardinal Health Completes Biotech Acquisition
8. Beckman Coulter Completes Acquisition of Olympus Lab-Based Diagnostics Business
9. Oncolytics Biotech Inc. Successfully Completes 100-Litre cGMP Production of REOLYSIN(R)
10. OncoGenex Pharmaceuticals Completes $9.5 Million Registered Direct Offering
11. GlaxoSmithKline Completes Acquisition of Stiefel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2012)... companies that are first to meet healthcare,s new ... competition for market share and brand differentiation, according to ... (HRI) at PwC US.  Physicians, health insurers and patients ... work and affect total medical costs.  Yet an HRI ... provided by the biopharmaceutical industry no longer suffices.   ...
(Date:5/16/2012)... trial, a paralyzed woman was able to reach for and ... first time in nearly 15 years by using her ... in part by the National Institutes of Health, is evaluating ... BrainGate neural interface system. This is a type of ... technology under the brain,s control. , A report published today ...
(Date:5/16/2012)... 2012 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: ... and marketer of medical devices worldwide, announced today ... its agreement for its full line of physiological ... Mindray provides monitoring that can meet the patient ... surgery centers for HealthTrust members. The new V-Series ...
(Date:5/15/2012)... May 15, 2012  OrbusNeich today announced that 12-month ... and safety outcomes involving the use of the company,s ... ® Liberte ® paclitaxel-eluting stent. The data ... I at the Lukaskrankenhaus in Neuss, Germany, at EuroPCR ... set, the clinically driven target lesion failure (TLF) rate ...
Breaking Biology Technology:New Competitive Arena Emerges for Pharmaceutical Companies in Healthcare's Changing Payment Landscape, Finds PwC Health Research Institute Study 2New Competitive Arena Emerges for Pharmaceutical Companies in Healthcare's Changing Payment Landscape, Finds PwC Health Research Institute Study 3New Competitive Arena Emerges for Pharmaceutical Companies in Healthcare's Changing Payment Landscape, Finds PwC Health Research Institute Study 4New Competitive Arena Emerges for Pharmaceutical Companies in Healthcare's Changing Payment Landscape, Finds PwC Health Research Institute Study 5New Competitive Arena Emerges for Pharmaceutical Companies in Healthcare's Changing Payment Landscape, Finds PwC Health Research Institute Study 6Paralyzed individuals use thought-controlled robotic arm to reach and grasp 2Paralyzed individuals use thought-controlled robotic arm to reach and grasp 3Paralyzed individuals use thought-controlled robotic arm to reach and grasp 4Paralyzed individuals use thought-controlled robotic arm to reach and grasp 5Mindray Renews Agreement with HealthTrust Purchasing Group, L.P. to Provide Patient Monitoring Equipment 2OrbusNeich's Combo Dual Therapy Stent™ Demonstrates Favorable Clinical and Safety Outcomes at 12-Month Follow-Up 2OrbusNeich's Combo Dual Therapy Stent™ Demonstrates Favorable Clinical and Safety Outcomes at 12-Month Follow-Up 3OrbusNeich's Combo Dual Therapy Stent™ Demonstrates Favorable Clinical and Safety Outcomes at 12-Month Follow-Up 4
... COLUMBUS, Ohio -- Engineers at Ohio State University are ... from the same material found in pencils. , Experts ... found in graphite pencils -- holds the key to ... effects that could enable new kinds of electronics. , ...
... VIEW, Calif., March 31 Based on its recent analysis ... Polymers LLC with the 2009 North American Frost & Sullivan ... to lead innovation in the field of styrenic block copolymers ... over four decades, the company,s new family of SBCs, the ...
... Pharmaceuticals, Inc. (NYSE: WPI ), a leading ... District Court for the District of Delaware has ruled ... tablets) does not infringe United States Patent No. 6,919,373 ... invalid. The opinion, dated March 30, 2009, was ...
Other Biology Technology:Researchers find better way to manufacture fast computer chips 2Researchers find better way to manufacture fast computer chips 3Frost & Sullivan Recognizes Kraton Polymers for Developing a New Generation of Polymer Grades Suitable for High-Speed Processing in Nonwoven Manufacture 2Frost & Sullivan Recognizes Kraton Polymers for Developing a New Generation of Polymer Grades Suitable for High-Speed Processing in Nonwoven Manufacture 3Frost & Sullivan Recognizes Kraton Polymers for Developing a New Generation of Polymer Grades Suitable for High-Speed Processing in Nonwoven Manufacture 4Frost & Sullivan Recognizes Kraton Polymers for Developing a New Generation of Polymer Grades Suitable for High-Speed Processing in Nonwoven Manufacture 5Delaware Court Rules That Watson Does Not Infringe Patent Related to Generic Version of Concerta(R) and Declares Patent Invalid 2
(Date:5/21/2012)... 2012  Chiltern International Limited (Chiltern), a global ... been recognized with a CRO Leadership Award in ... Regulatory. The awards are given by Life Science ... Nice Insight. Glenn Kerkhof ... be recognized as a CRO leader in the ...
(Date:5/21/2012)... (WHOI) have conducted a new study to measure levels ... The study, recently published in the journal Biogeosciences ... the Arctic Ocean,s carbon cyclethe pathway through which carbon ... will also offer an important point of reference for ... and how the ecosystem responds to rising global temperatures. ...
(Date:5/21/2012)... FLA.Robert van Woesik, Florida Institute of Technology professor ... grant from the National Science Foundation for research ... project will develop quantitative approaches to assess the ... are decimating the corals. When diseases cluster they ... a secondary cause of infection., Although diseases are ...
Breaking Biology News(10 mins):Chiltern Wins CRO Leadership Award From Life Science Leader 2New study by WHOI scientists provides baseline measurements of carbon in Arctic Ocean 2New study by WHOI scientists provides baseline measurements of carbon in Arctic Ocean 3Acne Psoriasis Meds Dont Raise Fracture Risk 72216 1Survey Finds Those Over 50 Are Less Stressed 72213 1Survey Finds Those Over 50 Are Less Stressed 72213 2Survey Finds Those Over 50 Are Less Stressed 72213 3Euthanasia and the use of end of life drugs without explicit request 72210 1Euthanasia and the use of end of life drugs without explicit request 72210 2
... and Switzerland has shown that carbon nanotubes may be ... 21 in the advance online edition of the journal ... in the search to find ways to "bypass" faulty ... which, like neurons, are highly electrically conductive, form extremely ...
... BOSTON, Mass. (Dec. 21, 2008) Modern humans left Africa ... was responsible for nearly all of the human population that ... that men and women weren,t equal partners in that exodus. ... non-sex chromosomes, the researchers found evidence that men probably outnumbered ...
... Washington, DC U.S. Forest Service Southern Research Station ... Presidential Early Career Award for Scientists and Engineers during ... among the nearly 70 scientists and engineers receiving the ... scientist or engineer can receive in the United States. ...
Other Biology News:New 'smart' materials for the brain 2Haag honored with Presidential Early Career Scientists Award 2
Homo sapiens similar to Cytosolic acyl coenzyme A thioester hydrolase Antigen: Peptide...
Cag-A (IgG) -Ab EIA Sample Size: 10 l...
... a protein ribonuclease inhibitor that noncovalently binds and ... is seen with RNase 1, T1, T2, H, ... human placental ribonuclease inhibitor in that it has ... not release active RNase in the absence of ...
... that has been shown to help maintain the ... by reverse transcription, in vitro RNA transcription, and ... tightly binds RNases in a 1:1 ratio. It ... as RNase A, RNase B, RNase C, and ...
Biology Products: